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Use of vacuum-assisted closure (VAC) therapy in
treating lymphatic complications after vascular
procedures: New approach for lymphoceles
Osama Hamed, MD,a Patrick E. Muck, MD,a J. Michael Smith, MD,a Kelli Krallman, MS,b and
Nathan M. Griffith, PhD,b Cincinnati, Ohio
Objective: Lymphatic complications, such as lymphocutaneous fistula (LF) and lymphocele, are relatively uncommon after
vascular procedures, but their treatment represents a serious challenge. Vacuum assisted closure (VAC) therapy has been
reported to be an effective therapeutic option for LF, but the effectiveness of VAC therapy for lymphoceles is unclear.
Methods: For LF, we apply the VAC directly to the skin defect after extending it to achieve a clean wound of at least one
inch in length. To treat lymphocele, we convert the lymphocele to a LF in a sterile fashion by making a one inch incision
in the overlying skin and applying the VAC. The setting was a community teaching hospital. We used 10 patients that we
treated with VAC therapy for LF (n  4) and lymphoceles (n  6).
Results:Duration of in-patient stay, duration of in-patient VAC treatment, duration of out-patient VAC treatment, total
duration of VAC treatment. The median duration of in-patient stay was 4 (range, 0-18) days, the median duration of
in-patient VAC treatment was 1 (range, 0-5) days, the median duration of out-patient VAC treatment was 16 (range,
7-28) days), and the median total duration of VAC therapy was 18 (range, 13-29) days. Successful wound healing was
achieved in all patients with no recurrence after VAC removal. VAC therapy for treatment of both LFs and lymphoceles
resulted in early control of drainage, rapid wound closure, and short hospital stays.
Conclusion: Our results suggest that VAC therapy is a convenient and effective therapeutic option for both LFs and
lymphoceles. ( J Vasc Surg 2008;48:1520-3.)Lymphatic complications, such as lymphocutaneous
fistula (LF) and lymphocele, are relatively uncommon after
vascular procedures, but they represent a serious challenge
for surgeons. A lymphocele is a cystic collection of lym-
phatic fluid from a disrupted lymphatic channel that forms
a pocket in the soft tissue of the healing wound. Continued
fluid accumulation in fresh wounds may cause wound dis-
ruption and continued lymphatic drainage, which consti-
tute a LF.1 Lymphatic complications most commonly oc-
cur in the groin after vascular exposure, but they can occur
elsewhere in the body, including the neck. Significant risk
factors are previous groin dissection, aortobifemoral recon-
struction, and presence of a foreign body.2-7 These complica-
tions represent significant potential morbidity and mortality.6
Patients with lymphatic complications have increased
length of hospital stay, ranging from 22 to 36 days, and
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1520significantly increased risk of wound infection, reportedly
up to 18%.3,5,6 In the case of an underlying prosthetic graft,
lymphatic complications can result in possible graft infec-
tion with the need for graft removal. This represents a
significant health care utilization burden and source of
morbidity.
Several therapeutic options have been described in the
literature for treatment of both LF and lymphocele (Table
I, online only). Treatments for LF include conservative
dressing changes,8,9 leg elevation,10 pressure dressings,
drain placement, local irradiation,10 surgical ligation of
the leaking lymphatic channel,7,11,12 and in the case of
an infected graft, muscle flap coverage after graft re-
moval.7,13,14 These treatment modalities are associated
with variable degrees of success. Existing literature supports
early identification through surgical exploration and lym-
phatic ligation,7,11,12 but this exposes the patient to an
additional invasive procedure that increases cost and length
of hospital stay.
Available therapeutic options for lymphoceles include
conservative out-patient observation, percutaneous drain-
age, sclerotherapy with bleomycin, doxycyclin or ethanol,
local irradiation, videoscopic argon beam coagulation, sur-
gical exploration with lymphatic ligation, and muscle flap
coverage (Table I, online only).2,15-19 There is no consen-
sus in the literature regarding the preferred treatment of
lymphoceles.
Vacuum-assisted closure (VAC) was reported as a novel
therapeutic option for lymphocutaneous fistula in two small
case series by Abai et al and Greer et al (total 5 patients).1,20
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of VAC for lymphoceles.
In this study, we describe our experience with VAC
therapy over the last 4 years in treating LFs and lymphoce-
les after various vascular procedures.
METHODS
We retrospectively reviewed the charts of 10 patients
(five female) who developed lymphatic complications after
surgery and were treated with VAC therapy (Kinetic Con-
cepts, San Antonio, Tex at Good Samaritan Hospital in
Cincinnati, Ohio) between July 2005 and October 2007.
The following demographic and medical background vari-
ables were recorded for all patients: age, gender, body mass
index (BMI), presence of risk factors (ie, diabetes, hyper-
tension), previous disruption of lymphatics (eg, previous
surgery, radiation), type of original surgery, presence of
graft, time from surgery to diagnosis of lymphatic compli-
cation, site and type of lymphatic complication, time from
diagnosis of lymphatic complication to VAC treatment,
and total duration of VAC therapy. Post-VAC therapy
follow-up was also recorded. This study was granted full
approval of the Institutional Review Board. All data analysis
was performed using SPSS 15.0 (SPSS Corporation, Chi-
cago, Ill).
The diagnosis of LF is made clinically based on clear
fluid drainage from the incision. We start with a conserva-
tive treatment approach of heavy dressings and bed rest. If
the patient is still saturating multiple heavy dressings and
drainage is not decreasing after 24-48 hours, we apply
VAC. We attempted exploration and identification of a
leaking lymphatic channel with and without blue dye in 3
patients (2 lymphoceles, 1 LF), but all 3 of these patients
experienced recurrence.
The development of lymphoceles after vascular proce-
dures is not uncommon in our institution due to our
oblique approach to expose the femoral artery. We use
clinical judgment, percutaneous aspiration (clear serous
fluid), and sometimes color Doppler sonography scan to
diagnose lymphocele. If a patient has a graft, a CT scan
should be obtained to evaluate the relation between the
fluid collection and the graft. In general, we do not advise
application of VAC directly on grafts. Most diagnoses of
lymphoceles are made during the first postoperative office
Table III. Results
Time period (days) All m
Surgery to diagnosis of complication 2
Diagnosis of complication to start of VAC treatment 1
Duration of in-patient stay
Duration of in-patient VAC treatment
Duration of out-patient VAC treatment 1
Total duration of VAC treatment 1
Duration of follow-upa 1
aTime is in months.visit – typically patients have nonpulsatile groin swellingwith no evidence of overlying infection. We initially at-
tempt to treat symptomatic lymphoceles with percutaneous
aspirations in the office to relieve patient symptoms. If a
patient has had symptomatic recurrence after multiple as-
pirations (average 4-5 times), we apply VAC by converting
the lymphocele to LF.
We use the regular black sponge polyurethane (PU)
foam dressing (GranuFoam Dressing, KCI Licensing, Inc.,
San Antonio, Tex) and continuous suction at 125 mmHg.
We change the dressings three times a week and see patients
in the office every 2 weeks, unless a complication requires
urgent attention. We receive a report from the visiting
nurse after every dressing change. The decision to stop the
VAC is based on no drainage from the wound for 2-3 days
and good wound healing in terms of granulation tissue
formation. We then instruct patients to initiate simple wet
to dry dressing until the wound completely heals. None of
our patients required skin graft because the skin defect after
removal of VAC is small enough to allow healing with
secondary intention.
RESULTS
Demographic and descriptive information for the cases
are presented in Table II (online only). The mean age and
BMI of patients in the sample was 65 / 16 years and
24 / 4 kg/m2, respectively. Six patients had comorbid
diabetes mellitus; 7 patients had comorbid hypertension.
Nine patients in the sample had groin lymphatic complica-
tions after surgery and 1 patient had a neck lymphatic
complication. Four patients had a previous disruption of
their groin lymphatics. Four grafts were involved in the
surgical field; none of these grafts were exposed or in direct
contact with VAC. Results related to duration of time from
surgery to wound healing for all cases and across type of
lymphatic complication are provided in Table III. The
median duration between diagnosis of lymphatic complica-
tions and VAC application was 12 days; the shortest time
from diagnosis to VAC application was 1 day. The median
duration of in-patient stay for treatment of lymphatic com-
plications was 4 days; patients used the VAC dressing
during their in-patient stay for a median of 1 day. The
average total duration of VAC treatment was 18 / 5
days. A success rate in achieving complete resolution of
n (range)
Lymphocutaneous fistula
median (range)
Lymphocele
median (range)
119) 7 (3-119) 26 (9-43)
480) 3 (1-18) 28 (1-480)
18) 5 (3-18) 1 (0-5)
5) 2 (1-5) 1 (0-2)
28) 15 (7-28) 18 (11-21)
-29) 17 (12-29) 18 (13-22)
32) 29 (4-32) 11 (5-29)edia
2 (3-
2 (1-
4 (0-
1 (0-
6 (7-
8 (13
2 (4-lymphatic complications with VAC was 100%, as no clini-
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average follow-up of 17 / 12 months.
DISCUSSION
Lymphatic complications after infrainguinal incision
and dissection are usually attributed to destruction during
the dissection without attention to detailed ligation of
small lymphatics. Based on the anatomy of the lymphatic
vessels in this region, a vertical dissection minimizes disrup-
tion and decreases subsequent formation of a lymphocele
or LF. A vertical groin incision is associated with less
postoperative lymphatic complications compared to an
oblique incision.21-23 However, oblique incisions in the
groin as an access for femoral artery during endovascular
repair of abdominal aortic aneurysm (AAA) are associated
with less infection, especially in morbidly obese pa-
tients.22,24,25 In addition to the direction of groin incision,
some surgeons advocate the use of fibrin glue to help
prevent lymphatic complications.23
Despite all efforts to prevent lymphatic complications,
the overall reported incidence of groin lymphatic compli-
cations after vascular procedures ranges from 1.2 to
5.1%.2-6 These complications are a major challenge for the
surgeon, especially when a prosthetic material is involved in
the underlying wound. There is no consensus on optimal
treatment for lymphatic complications. The application of
surgical treatments suggested in the literature may increase
the cost and duration of hospital stays and exposes patients
to an additional invasive procedure.
Since its introduction by Argenta and coworkers in
1995 as a wound treatment modality, VAC treatment has
proved to be one of the most effective methods in the
management of all types of wounds.26,27 TheUnited States
Food & Drug Administration (US FDA) granted approval
for wound treatment by VAC device in 1995. The first
clinical data in the English language on its use in a variety of
chronic wound conditions was published in 1997.26
Initial studies on animals showed that VAC increased
granulation tissue formation by 103  35% per day com-
pared to wet to dry dressing.28 This is caused by increasing
blood flow to the wound, decreasing the interstitial fluid
and edema, removal of inflammatory mediators that are
detrimental to wound healing, and finally by increasing
local cellular response in the wound. VAC also has been
shown to decrease the bacterial counts in grossly infected
wounds.28
Demaria et al reported VAC to be a useful method to
treat groin infection after emergency vascular proce-
dures.29 Two years later, Dosluoglu et al reported the
usefulness of VAC in preserving infected exposed vascular
grafts without muscle flap in 4 high-risk surgical patients.30
Pinocy et al also used VAC to treat periprosthetic soft tissue
infection of the groin with good results.31
Greer et al reported their experience with VAC treat-
ment for LF in the groin in a small case series consisting of
2 patients.20 The authors reported good results and con-
cluded that VAC therapy was a promising treatment op-
tion. In another small case series, Abai et al reported goodresults of negative pressure wound therapy in the treatment
of groin LF in three cases at their institution.1 The mean
time of cessation of lymphatic drainage in their case series
was 14 days.
To the best of our knowledge, the present study is the
first to report the use of VAC therapy following conversion
of recurrent lymphocele to LF in sterile fashion. Although
we are not suggesting that VAC should be the primary
therapy for patients with lymphatic complications after
vascular procedures, and we are not stating that every
lymphocele should be treated with VAC, these results
suggest that VAC is an effective alternative treatment op-
tion for recurrent symptomatic lymphocele or LF that has
failed out-patient conservative management. Moreover,
VAC is readily available, easy to use, and has good patient
satisfaction, especially with small portable home devices.
CONCLUSION
In this case series, we described the use of VAC to treat
nine lymphatic complications after variable vascular proce-
dures with 100% success rate and no recurrence. We had
four grafts involved and we were able to save them with no
graft infection. VAC is an effective, readily-available treat-
ment option that is less invasive than exploration and
ligation of leaking lymphatics and provides early control of
drainage and rapid wound closure.
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Table I, online only. Therapeutic options for lymphatic complications
Study/treatment N LF/lymphocele Previous intervention
Duration from treatment
to resolution (days)
McShannic et al 19978a 32 29/3 None 5
Exploration and ligation 24 —x 2
Conservative management 8 — 38
Procellini et al 20029 23 — None
Out-patient limited ambulation; limb
elevation; pressure dressings
0/23 21
Roberts et al 19932 8 3/5 —
Conservative treatment (bed rest; recurrent
percutaneous aspirations; pressure
dressing)
8 3/5
Exploration, identification and ligation of
leaking lymphatics with lymphocele
excision
8 3/5 Failed conservative management
Tyndall et al 19943b 41 28/13 None
Conservative treatment (bed rest; IV
antibiotics; aggressive local wound care)
29 18/11 24
Exploration and ligation with meticulous
closure
12 10/2 9
Schwartz et al 199512 17 8/9
Conservative management; bed rest;
elevation; pressure dressing; oral antibiotics
17 8/9 None 74
Operative (exploration and ligation with dye) 10 4/6 Failed conservative management 18
Shermak et al 20057 34 —
Conservative out-patient management, bed
rest, aspiration, doxycyclin injection,
incision and drainage
14 — — —
Exploration, identification, and ligation of
leaking lymphatic with wall excision
15 — 7 patients failed less invasive treatment —
Muscle flap coverage 22 — 10 patients failed operative and
nonoperative treatment
—
Stadelmann et al 200113 19 —
Exploration, identification, and ligation of
leaking lymphatic channel using isosulfan
blue dye under general anesthesia; bed rest
for 5 days post op; no excision of
lymphocele wall. Three patients needed
muscle flap coverage.
4/15 6 patients failed previous operative
intervention, 3 patients failed
conservative management
—
Kwaan et al 197911 12 12/0 None
Conservative management; pressure dressing,
systemic antibiotics; immobilization;
application of povidone-iodine
7 — 28-42
Exploration, identification and ligation of
leaking lymphatic channel (with and
without dye)
5 — —
aNumber of references in this paper.
bOperative intervention for lymphoceles did not reduce hospital stay or infectious wound complications. Repetitive aspirations also did not affect rapidity of
resolution or increase infectious complications.
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Table I, online only. Continued.
Length of hospital stay (days) Complications Recurrence rate Follow-up (months)
42
11 — 0/24 (0%)
26 — 0/8 (0%)
12
11 days (in patients diagnosed while in
hospital)
1 infection 0/23 (0%)
— 3 to 51
— 8/8 (100%)
—
41
25 5 infections, one in graft resulting in
limb amputations
0/29 (0%)
17 No infections; 1 pulmonary
embolism
2/12 (17%)
19 5/17 10/17 (59%) 14
3 0 1/10 (10%) 26
— — 14/14 (100%) —
5 — 4/15 (27%) —
9 4/22 — 18
At least 5 days for bed rest then activity
advanced, pressure dressings for 2
weeks, sutures removed at 3 weeks
1 groin hematoma; 1 abscess at blue
dye injection site; 1groin abscess
blue hue at injection site
0/15 (0%) 18
28 3 infections, one with graft
involvement resulting in
amputations
1/7 (with persistent drainage) —
11 None 0% —
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Table II, online only. Cases
Patient 1 2 3 4
Age 73 85 69 63
Gender Male Female Male Male
BMI (Kg/m2) 26.0 25.9 22.8 26.6
DM Y Y Y Y
HTN N Y Y Y
Previous disruption to
lymphatics
APR for rectal Ca, with
history of radiation
R hip replacement N N
Type of surgery FA cutdown for EVAR R FA cutdown for
EVAR
FA cutdown for
retroperitoneal Aorto-
Bifem
FA cutdown for
Aorto-Bifem
Graft N N Y Y
Surgery to diagnosis
(days)
22 119 7 6
Site of lymphatic
complication
L Groin R Groin R Groin R Groin
Type of lymphatic
complication
Lymphocele LF LF LF
In-patient treatment for
lymphatic
complications
5 3 18 4
Treatment before VAC
(days)
Percutaneous aspiration;
bed rest; exploration,
resection,
identification, and
ligation; Fibrin glue
application
Heavy dressing Dressing change; exploration,
identification, and ligation
Dressing change;
bed rest
Diagnosis to VAC (days) 480 1 5 1
Duration of VAC (days) 22 14 13 19
Follow-up (months) 29 30 32 27
BMI, Body mass index;DM, diabetes mellitus;HTN, hypertension; VAC, vacuum assisted closure;APR, abdominoperineal resection;Ca, cancer; FA, femoral
artery; EVAR, endovascular aortic aneurysm repair; LF, lymphocutaneous fistula; Aorto-Bifem, aortobifemoral bypass grafting; GSV, greater saphenous vein;
MV, mitral valve; Y, yes; N, no; R, right; L, left.
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Table II, online only. Continued.
5 6 7 8 9 10
36 51 59 47 80 82
Female Female Male Female Male Female
25.4 17.8 27.1 31.0 22.0 20.0
N Y Y N N N
N Y Y N Y Y
N N N N FA cutdown for
cannulation
for robotic
assisted MV
repair
R femoral to
popliteal
bypass graft
Ligation and division of
GSV at sapheno-
femoral junction
L carotid to
subclavian
bypass graft
FA cutdown for
cannulation
during
robotic
assisted MV
repair
FA cutdown for
cannulation
during
robotic
assisted MV
repair
Removal of
Goretex
suture for
recurrent L
groin
infection
R common FA
angioplasty;
thrombectomy
of femoral to
popliteal graft
N Y N N N Y
42 22 30 43 9 3
R Groin L Neck R Groin R Groin L Groin R Groin
Lymphocele Lymphocele Lymphocele Lymphocele Lymphocele LF
0 5 1 0 0 5
Recurrent percutaneous
aspirations; excision
of lymphocele and
primary closure
Observation; oral
antibiotics
Recurrent
percutaneous
aspirations
Recurrent
percutaneous
aspirations
Recurrent
percutaneous
aspirations;
pressure
dressing
Heavy pressure
dressing
122 1 39 7 16 18
20 13 22 16 16 29
10 13 11 5 5 4
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